Complicated Intra-abdominal Infections (cIAI) - Epidemiology Forecast - 2032

January 2022 | 60 pages | ID: C031A68FFE86EN
DelveInsight

Abstracts

This report can be delivered to the clients within 5-7 Business Days

DelveInsight's 'Complicated Intra-abdominal Infections (cIAI) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Complicated Intra-abdominal Infections (cIAI) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2019-2032

Complicated Intra-abdominal Infections (cIAI) Understanding

The DelveInsight Complicated Intra-abdominal Infections (cIAI) epidemiology report gives a thorough understanding of the Complicated Intra-abdominal Infections (cIAI) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Complicated Intra-abdominal Infections (cIAI) in the US, Europe, and Japan. The report covers the detailed information of the Complicated Intra-abdominal Infections (cIAI) epidemiology scenario in seven major countries (US, EU5, and Japan).

Complicated Intra-abdominal Infections (cIAI) Epidemiology Perspective by DelveInsight

The Complicated Intra-abdominal Infections (cIAI) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Complicated Intra-abdominal Infections (cIAI) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Complicated Intra-abdominal Infections (cIAI) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Complicated Intra-abdominal Infections (cIAI) Detailed Epidemiology Segmentation

The Complicated Intra-abdominal Infections (cIAI) epidemiology covered in the report provides historical as well as forecasted Complicated Intra-abdominal Infections (cIAI) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

The DelveInsight Complicated Intra-abdominal Infections (cIAI) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

• The Complicated Intra-abdominal Infections (cIAI) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The Complicated Intra-abdominal Infections (cIAI) Epidemiology Report and Model provide an overview of the global trends of Complicated Intra-abdominal Infections (cIAI) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight into the historical and forecasted patient pool of Complicated Intra-abdominal Infections (cIAI) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps recognize the growth opportunities in the 7MM for the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Complicated Intra-abdominal Infections (cIAI)
• The report provides the segmentation of the Complicated Intra-abdominal Infections (cIAI) epidemiology

Report Highlights

• 11-year Forecast of Complicated Intra-abdominal Infections (cIAI) epidemiology
• 7MM Coverage
• Prevalent and Diagnosed Cases of Complicated Intra-abdominal Infections (cIAI)
• Cases of Complicated Intra-abdominal Infections (cIAI) by Mutation Types
• Complicated Intra-abdominal Infections (cIAI) Cases associated with Clinical Manifestations

KOL views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Complicated Intra-abdominal Infections (cIAI)?
• What are the key findings pertaining to the Complicated Intra-abdominal Infections (cIAI) epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2019-2032)?
• What would be the total number of patients of Complicated Intra-abdominal Infections (cIAI) across the 7MM during the forecast period (2019-2032)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?
• What is the disease risk, burden and unmet needs of Complicated Intra-abdominal Infections (cIAI)?
• What are the currently available treatments of Complicated Intra-abdominal Infections (cIAI)?

Reasons to buy

The Complicated Intra-abdominal Infections (cIAI) Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Complicated Intra-abdominal Infections (cIAI) market
• Quantify patient populations in the global Complicated Intra-abdominal Infections (cIAI) market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Complicated Intra-abdominal Infections (cIAI) therapeutics in each of the markets covered
• Understand the magnitude of Complicated Intra-abdominal Infections (cIAI) population by its epidemiology
• The Complicated Intra-abdominal Infections (cIAI) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Contents

1. KEY INSIGHTS

2. EXECUTIVE SUMMARY OF COMPLICATED INTRA-ABDOMINAL INFECTIONS (CIAI)

3. COMPLICATED INTRA-ABDOMINAL INFECTIONS (CIAI): DISEASE BACKGROUND AND OVERVIEW

3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis

4. PATIENT JOURNEY

5. EPIDEMIOLOGY AND PATIENT POPULATION

5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
  5.3.1. Complicated Intra-abdominal Infections (cIAI) Epidemiology Scenario in the 7MM (2019- 2032)
5.4. United States Epidemiology
  5.4.1. Complicated Intra-abdominal Infections (cIAI) Epidemiology Scenario in the United States (2019- 2032)
5.5. EU-5 Country-wise Epidemiology
  5.5.1. Germany Epidemiology
    5.5.1.1. Complicated Intra-abdominal Infections (cIAI) Epidemiology Scenario in Germany (2019- 2032)
  5.5.2. France Epidemiology
    5.5.2.1. Complicated Intra-abdominal Infections (cIAI) Epidemiology Scenario in France (2019- 2032)
  5.5.3. Italy Epidemiology
    5.5.3.1. Complicated Intra-abdominal Infections (cIAI) Epidemiology Scenario in Italy (2019- 2032)
  5.5.4. Spain Epidemiology
    5.5.4.1. Complicated Intra-abdominal Infections (cIAI) Epidemiology Scenario in Spain (2019- 2032)
  5.5.5. United Kingdom Epidemiology
    5.5.5.1. Complicated Intra-abdominal Infections (cIAI) Epidemiology Scenario in the United Kingdom (2019-2032)
5.6. Japan Epidemiology
  5.6.1. Complicated Intra-abdominal Infections (cIAI) Epidemiology Scenario in Japan (2019- 2032)

6. TREATMENT ALGORITHM, CURRENT TREATMENT, AND MEDICAL PRACTICES

6.1. Complicated Intra-abdominal Infections (cIAI) Treatment and Management
6.2. Complicated Intra-abdominal Infections (cIAI) Treatment Algorithm

7. KOL VIEWS

8. UNMET NEEDS

9. APPENDIX

9.1. Bibliography
9.2. Report Methodology

10. DELVEINSIGHT CAPABILITIES

11. DISCLAIMER

12. ABOUT DELVEINSIGHT

*The table of contents is not exhaustive; will be provided in the final report

List Of Tables

LIST OF TABLES

List of Table:
Table 1: Complicated Intra-abdominal Infections (cIAI) Epidemiology in 7MM (2019-2032)
Table 2: Complicated Intra-abdominal Infections (cIAI) Diagnosed and Treatable Cases in 7MM (2019-2032)
Table 3: Complicated Intra-abdominal Infections (cIAI) Epidemiology in the United States (2019-2032)
Table 4: Complicated Intra-abdominal Infections (cIAI) Diagnosed and Treatable Cases in the United States (2019-2032)
Table 5: Complicated Intra-abdominal Infections (cIAI) Epidemiology in Germany (2019-2032)
Table 6: Complicated Intra-abdominal Infections (cIAI) Diagnosed and Treatable Cases in Germany (2019-2032)
Table 7: Complicated Intra-abdominal Infections (cIAI) Epidemiology in France (2019-2032)
Table 8: Complicated Intra-abdominal Infections (cIAI) Diagnosed and Treatable Cases in France (2019-2032)
Table 9: Complicated Intra-abdominal Infections (cIAI) Epidemiology in Italy (2019-2032)
Table 10: Complicated Intra-abdominal Infections (cIAI) Diagnosed and Treatable Cases in Italy (2019-2032)
Table 11: Complicated Intra-abdominal Infections (cIAI) Epidemiology in Spain (2019-2032)
Table 12: Complicated Intra-abdominal Infections (cIAI) Diagnosed and Treatable Cases in Spain (2019-2032)
Table 13: Complicated Intra-abdominal Infections (cIAI) Epidemiology in the United Kingdom (2019-2032)
Table 14: Complicated Intra-abdominal Infections (cIAI) Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Table 15: Complicated Intra-abdominal Infections (cIAI) Epidemiology in Japan (2019-2032)
Table 16: Complicated Intra-abdominal Infections (cIAI) Diagnosed and Treatable Cases in Japan (2019-2032)

List Of Figures

LIST OF FIGURES

List of Figures
Figure 1 Complicated Intra-abdominal Infections (cIAI) Epidemiology in 7MM (2019-2032)
Figure 2 Complicated Intra-abdominal Infections (cIAI) Diagnosed and Treatable Cases in 7MM (2019-2032)
Figure 3 Complicated Intra-abdominal Infections (cIAI) Epidemiology in the United States (2019-2032)
Figure 4 Complicated Intra-abdominal Infections (cIAI) Diagnosed and Treatable Cases in the United States (2019-2032)
Figure 5 Complicated Intra-abdominal Infections (cIAI) Epidemiology in Germany (2019-2032)
Figure 6 Complicated Intra-abdominal Infections (cIAI) Diagnosed and Treatable Cases in Germany (2019-2032)
Figure 7 Complicated Intra-abdominal Infections (cIAI) Epidemiology in France (2019-2032)
Figure 8 Complicated Intra-abdominal Infections (cIAI) Diagnosed and Treatable Cases in France (2019-2032)
Figure 9 Complicated Intra-abdominal Infections (cIAI) Epidemiology in Italy (2019-2032)
Figure 10 Complicated Intra-abdominal Infections (cIAI) Diagnosed and Treatable Cases in Italy (2019-2032)
Figure 11 Complicated Intra-abdominal Infections (cIAI) Epidemiology in Spain (2019-2032)
Figure 12 Complicated Intra-abdominal Infections (cIAI) Diagnosed and Treatable Cases in Spain (2019-2032)
Figure 13 Complicated Intra-abdominal Infections (cIAI) Epidemiology in the United Kingdom (2019-2032)
Figure 14 Complicated Intra-abdominal Infections (cIAI) Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Figure 15 Complicated Intra-abdominal Infections (cIAI) Epidemiology in Japan (2019-2032)
Figure 16 Complicated Intra-abdominal Infections (cIAI) Diagnosed and Treatable Cases in Japan (2019-2032)
*The table of contents is not exhaustive; will be provided in the final report